Patient-reported outcomes in the Translational Breast Cancer Research Consortium

Deborah J. Bowen, Eileen H. Shinn, Sophie Gregrowski, Gretchen Kimmick, Laura S. Dominici, Elizabeth S. Frank, Karen Lisa Smith, Gabrielle Rocque, Kathryn J. Ruddy, Teri Pollastro, Michelle Melisko, Tarah J. Ballinger, Oluwadamilola M. Fayanju, Antonio C. Wolff

Research output: Contribution to journalComment/debate

Abstract

Members of the Translational Breast Cancer Research Consortium conducted an expert-driven literature review to identify a list of domains and to evaluate potential measures of these domains for inclusion in a list of preferred measures. Measures were included if they were easily available, free of charge, and had acceptable psychometrics based on published peer-reviewed analyses. A total of 22 domains and 52 measures were identified during the selection process. Taken together, these measures form a reliable and validated list of measurement tools that are easily available and used in multiple cancer trials to assess patient-reported outcomes in relevant patients.

Original languageEnglish (US)
Pages (from-to)922-930
Number of pages9
JournalCancer
Volume126
Issue number5
DOIs
StatePublished - Mar 1 2020

Keywords

  • breast cancer consortium
  • breast cancer treatment
  • clinical trials
  • patient-reported outcomes
  • translational clinical judgements

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Patient-reported outcomes in the Translational Breast Cancer Research Consortium'. Together they form a unique fingerprint.

  • Cite this

    Bowen, D. J., Shinn, E. H., Gregrowski, S., Kimmick, G., Dominici, L. S., Frank, E. S., Smith, K. L., Rocque, G., Ruddy, K. J., Pollastro, T., Melisko, M., Ballinger, T. J., Fayanju, O. M., & Wolff, A. C. (2020). Patient-reported outcomes in the Translational Breast Cancer Research Consortium. Cancer, 126(5), 922-930. https://doi.org/10.1002/cncr.32615